S'abonner

Safety and efficacy of cytology brushings versus standard FNA in evaluating cystic lesions of the pancreas: a pilot study - 22/08/11

Doi : 10.1016/j.gie.2006.08.047 
Mohammad Al-Haddad, MD, Massimo Raimondo, MD, Timothy Woodward, MD, Murli Krishna, MD, Surakit Pungpapong, MD, Kyung Noh, MD, Michael B. Wallace, MD, MPH
Current affiliations: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA 

Reprint requests: Michael B. Wallace, MD, Division of Gastroenterology and Hepatology, Mayo Clinic Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224.

Jacksonville, Florida, USA

Abstract

Background

Cystic neoplastic lesions of the pancreas (CNLP) are increasingly detected and are associated with a potential for malignant transformation. Diagnostic assessment of these lesions is often limited by the cystic nature and focality of neoplastic progression of these lesions. EUS-guided FNA (EUS-FNA) of cyst fluid and exfoliated cells is one of the most accurate methods of diagnosis but still has limited sensitivity. A new, through-the-needle cytologic brush system has recently been approved for use during EUS evaluation of cystic lesions of the pancreas.

Objective

To evaluate the cytologic yield and safety profile of the new cytobrush compared with conventional FNA in evaluating CNLP.

Design

Ten consecutive patients with CNLP were included. All cysts were sampled by standard EUS-FNA (0.5 of cyst volume) followed by brush cytology, then by aspiration of the remaining fluid. Fluid samples were separately submitted (standard FNA and cytobrushings FNA) but were read by the same pathologist. Complications were assessed during the immediate postprocedure period (2-3 hours) and by a telephone call conducted approximately 30 days after the procedure to inquire about any new symptoms, including abdominal pain, melena, hematochezia, hematemesis, fever, nausea, and vomiting.

Setting

High-volume EUS referral center.

Patients

Ten consecutive patients with CNLP that measured at least 20 mm in maximal dimension were included.

Main Outcome Measurements

Cellularity and presence of diagnostic cells on the FNA.

Results

In 7 of 10 cases, the EchoBrush specimen was superior to FNA in terms of cellularity and detection of diagnostic cells. Two cases had complications: 1 major and 1 minor intracystic bleed. No infection or pancreatitis was observed.

Limitations

The interpreting pathologist for the case was not blinded to the results of either of the samples. In addition, this pilot study represents only a single-center experience.

Conclusions

This study suggests that brush cytology specimens obtained at the time of EUS are superior to conventional FNA because of the higher yield of epithelial cells. It is unclear whether bleeding is more common after EchoBrush sampling; however, caution should be taken in patients who require anticoagulation until further data are available.

Le texte complet de cet article est disponible en PDF.

Plan


© 2007  American Society for Gastrointestinal Endoscopy. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 65 - N° 6

P. 894-898 - mai 2007 Retour au numéro
Article précédent Article précédent
  • The endoscope
  • John Baillie
| Article suivant Article suivant
  • Comprehensive esophageal microscopy by using optical frequency–domain imaging (with video)
  • Benjamin J. Vakoc, Milen Shishko, Seok H. Yun, Wang-Yuhl Oh, Melissa J. Suter, Adrien E. Desjardins, John A. Evans, Norman S. Nishioka, Guillermo J. Tearney, Brett E. Bouma

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.